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INTRODUCTION 
HIV / AIDS is becoming a major threat to the human population 
across the Globe. According to UNAIDS report, globally there were an 
estimated 33 million people living with HIV in 2008. There were about 2.7 
million new HIV infections and about 2 million AIDS related deaths in 
20082. The rate of new HIV infections has fallen in several countries, but has 
increased in developing countries. Provisional estimates show that there are 
22.7 lakh people living with HIV/AIDS in India by the end of 2008 with an 
estimated adult HIV prevalence of 0.29 percent47. Patient infected with HIV 
suffer from various opportunistic infections, as a result of profound 
impairment of cellular immunity by the virus. The spectrum of opportunistic 
infections in HIV-infected patients is related to the microflora of the local 
environment25. 
Bloodstream infections (BSI) are a major cause of morbidity and 
mortality among patients infected with HIV23,64 and is often associated with 
a poor prognosis22,33,39,51,57,60,61 , responsible for the immediate cause of death 
in up to 32% of cases, especially under particular conditions (e.g. 
intravenous drug abuse, use of a central venous catheter, neutropenia, and a 
low CD4 T-cell count)60 . Inappropriate empirical therapy and the presence 
of other immunosuppressive factors were independent risk factors for 
mortality. Ceftriaxone could be used as the initial empiric therapy for HIV-
infected patients with suspected CA BSI50.  
Patients with AIDS have  the greatest diversity of pathogens recovered 
from blood, including mycobacterial species, Bartonella henslae, 
Corynebacterium jeikeium, Shigella flexneri, unusual Salmonella species, 
Histoplasma capsulatum, Cryptococcus neoformans, and cytomegalovirus. 
As is typically observed in other hospitalized patients, organisms such as 
gram positive aerobic bacteria (e.g., Staphylococcus aureus, Enterococcus) 
and gram negative aerobic bacteria (e.g., Enterobacteriaceae, Pseudomonas 
aeruginosa) are common causes of bloodstream infections in 
immunocompromised patients8.  
 Only a few studies regarding the prevalence of blood stream 
infections in HIV infected patients are available from South India at present. 
I took up this study in our institution, to evaluate the prevalence of such 
infections in HIV patients in our setup in relation to their CD4 T lymphocyte 
counts and to ascertain the importance of blood culture examination for the 
detection of blood stream infections that aids in treatment, thereby 
decreasing the morbidity and mortality due to community acquired and 
nosocomial blood stream infections.  
 
 
AIMS OF THE STUDY 
 
1. To determine the prevalence of non mycobacterial blood stream 
infection in HIV positive and AIDS patients.   
2. To establish the causative organisms using the blood culture methods. 
3. To determine the antimicrobial susceptibility pattern of the isolates. 
4. To determine the risk factors, outcome and influence of long term 
prophylactic antibiotic treatment. 
5. To study the correlation between CD4 and the prevalence of blood 
stream infections.  
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
HUMAN IMMUNODEFICIENCY VIRUS 
AIDS was first recognized in the summer of 1981, when the US 
centers of disease control and prevention reported the unexplained 
occurrence of Pneumocystis jirovecii among homosexual men in Los 
Angeles and an outbreak of a rare form of cancer among gay men in New 
York and California, medically known as Kaposi sarcoma. Within months, 
the disease became recognized in male and female drug users and soon 
thereafter in recipients of blood transfusions and in hemophiliacs. As the 
epidemiologic pattern of the disease unfolded, it became clear that a microbe 
transmissible by sexual contact and blood or blood products or from mother 
to infants was the most likely etiologic agent. 
In 1983, Luc Montagnier isolated the virus from a patient with 
lymphadenopathy and by 1984 it was demonstrated clearly to be the 
causative agent of AIDS. In 1985, a sensitive enzyme linked immunosorbant 
assay was developed28. 
The etiologic agent of AIDS is HIV, which belongs to the family of 
human retroviruses and the subfamily of lentiviruses. There are two distinct 
types of human AIDS viruses namely HIV-1 and HIV-2. The two types are 
distinguished on the basis of genome organization and phylogenetic 
relationship with other primate lentiviruses29. 
The most common cause of HIV disease throughout the world is HIV-
1. HIV-2 was first identified in 1986 in West African patients and was 
originally confined to West Africa. However a number of cases have been 
identified through out the world28. 
HIV-1 is subdivided into 3 genetic groups designated M (Major), O 
(Outlier) and N (Non-M, Non-O) based on sequence diversity within the 
HIV-1 gag and env genes. HIV-1 group is divided into 9 sub-types (A-D, F-
H, and J&K)10. Subtypes differ in mode of transmission, geographical 
distribution and biological characteristics. Subtype C viruses are the most 
common worldwide. The predominant subtype in Europe and the America is 
Subtype B. Subtype C is prevalent in India48. 
HIV-1 and HIV-2 have the same mode of transmission. The most 
common mode of HIV infection is sexual transmission – both homosexual 
and heterosexual contact. Infection may also occur through inoculation of 
infected blood products, via transfusion of blood products, transplantation of 
infected tissues or through contaminated needle10. Large multi institutional 
studies have indicated the risk of transmission following skin puncture with 
needle contaminated with blood from a HIV infected person as 0.3% and 
after mucous exposure it is 0.09%. The other mode of transmission is from 
the infected mother to the child either intrapartum, perinatally or via breast 
milk28. 
The hallmark of HIV disease is a profound immunodeficiency 
resulting primarily from a progressive quantitative and qualitative deficiency 
of the subset of T lymphocytes referred to as helper T cells or inducer T 
cells. This subset of T cells is defined phenotypically by the presence on its 
surface of the CD4 molecule which serves as the primary receptor for HIV. 
HIV uses two major co-receptors namely CCR5 and CXCR4 for fusion and 
entry28. 
After attachment, HIV RNA and enzymes are released into the host 
cell. Viral replication requires reverse transcriptase (an RNA dependent 
DNA   polymerase) associated with HIV RNA, producing proviral DNA; 
this copying mechanism is prone to errors, resulting in frequent mutations. 
These mutations facilitate the generation of HIV that can resist control by the 
host’s immune system and by antiretroviral drugs. Proviral DNA enters the 
host cell’s nucleus and is integrated into the host DNA in a process that 
involves HIV integrase. With each cell division, the integrated proviral DNA 
is duplicated along with the host DNA. Proviral HIV DNA is transcribed to 
viral RNA and translated to HIV proteins, including the envelope 
glycoprotein 40 and 120. The HIV proteins are assembled into HIV virions 
at the inner cell membrane and budded from the cell surface; each host cell 
may produce thousands of virions. After budding, protease, another HIV 
enzyme, cleaves viral proteins, converting the immature virion into a mature, 
infectious form. 
The main consequence of HIV infection is damage to the immune 
system, specifically loss of CD4+ lymphocytes, which are involved in cell-
mediated and, to a lesser extent, humoral immunity. CD4+ lymphocyte 
depletion may result from the following: 
1. Direct cytotoxic effects of HIV replication 
2. Cell-mediated immune cytotoxicity 
3. Thymic damage that impairs lymphocyte production 
Infected CD4+ lymphocytes have a half-life of about 2 days, which is 
much shorter than that of uninfected CD4+ cells. Rates of CD4+ lymphocyte 
destruction correlate with plasma HIV level. Typically, during the initial or 
primary infection, HIV levels are highest (>106 copies/mL), and the CD4 
count drops rapidly. The normal CD4 count is about 750/µL, and the 
immunity is minimally affected if the count is > 350/µL. If the count drops 
below about 200/µL, a variety of opportunistic pathogens may produce 
clinical disease. The humoral immune system is also affected3 .  
LABORATORY INVESTIGATIONS FOR HIV INFECTION 
1. Laboratory methods for the diagnosis of HIV infection 
2. Laboratory methods for monitoring Stage and Progression of Infection. 
Laboratory methods for the diagnosis of HIV infection 
1. Indirect Methods (Antibody detection methods) 
2. Direct Methods. 
DETECTION OF SPECIFIC ANTIBODIES 
Detection of anti-HIV antibodies is the main stay of diagnosing HIV. 
Tests to detect specific antibodies can be classified into 
1. Screening tests 
2. Conventional ELISA 
3. Rapid tests 
Rapid tests are in vitro qualitative tests for the detection of antibodies to 
HIV-1 and HIV-2 in serum, plasma, whole blood, saliva and urine. 
• Immunoconcentration 
• Particle agglutination 
• Immunochromatography 
• Immunocomb 
Supplemental tests (Confirmatory tests) 
• Western Blot 
• Immunoblot 
• Lineimmuno assay 
• Indirect fluorescent antibody test 
• Radioimmunoprecipitation tests 
DIRECT DETECTION OF HIV INFECTION 
HIV Infection is diagnosed mainly by detecting the HIV antibodies. 
But there are situations where the serology is negative although there is 
definite evidence of exposure to HIV infection. Direct detection methods are 
needed in the following settings: 
4. To determine HIV status during the window period 
5. In health care workers, following accidental exposure to contaminated  
    blood. 
6. Also children born to HIV infected mother present dilemma as antibody 
positivity seen upto 18 months may be due to maternal antibodies. The 
diagnosis in each situation can be made by direct detection method like 
Detection of p24 antigen 
7. Detection of HIV specific DNA 
8. Isolation of virus by culture. 
Laboratory tests for monitoring stage and progression of HIV infection 
They are classified into  
Viral markers Immunologic markers 
Plasma HIV RNA load CD4 count 
P24 antigenemia  
Viral specific markers like antibodies to HIV antigens and soluble 
markers of immune activation like neopterin, beta2-microglobulin previously 
recommended for monitoring the course of HIV infection are no longer 
recommended. 
The close relationship between clinical manifestations of HIV 
infection and CD4+ T cell count has made measurements of the CD4 count 
as a routine part of the evaluation of HIV infected individuals. 
CD4 T cell counts 
The progressive depletion of CD4+ T lymphocytes is the cardinal 
event in the pathogenesis of infection by the human immunodeficiency virus. 
The number of these cells in the peripheral blood is the single most 
important parameter for monitoring the disease associated with HIV 
infection. 
Determinants of CD4+ T-cell counts and measurements of the HIV-
RNA levels in serum or plasma provides powerful tools for determining 
prognosis and monitoring response to therapy. 
Throughout the course of the disease, the total T cell levels remain 
fairly constant despite a fall in CD4 T lymphocyte count, due to a 
concomitant rise in CD8 T lymphocytes. Therefore, the ratio of CD4 T 
lymphocytes to CD8 T lymphocytes is an additional important measure of 
disease progression. Measurement of lymphocyte subsets is done by flow 
cytometry which is the gold standard for enumeration of CD4 T 
lymphocytes. 
CD4 T lymphocytes enumeration is also utilized as a surrogate marker 
for HIV-induced damage. The declining slope of CD4 T lymphocytes 
counts, indicates the speed of progression towards AIDS. While on therapy, 
improvement in CD4 T lymphocytes counts is indicative of the success of 
therapy. In resource-poor countries, with the arrival of generic drug for anti-
retroviral therapy, the need of for CD4 T lymphocytes counts are the criteria 
for initiating ART as well as monitoring the therapeutic response in a 
patient. 
Flow Cytometry: 
Flow Cytometry uses the principle of light scattering, light excitation 
and emission of fluorochrome molecules to generate specific multi-
parameter data from particles. The cellular suspension is incubated 
previously with monoclonal antibodies conjugated with different 
fluorochromes and it is introduced in the hydraulic system so that the cells 
pass individually through the flow chamber, where the laser beam intercepts 
the cells. This contact produces two different dispersion patterns: the frontal 
dispersion (Forward Scatter, A) gives us information about the cellular size, 
while lateral dispersion (Side Scatter, B) informs us about cellular 
complexity. The monoclonal antibodies linked to cellular surface is at the 
same time excited by the laser and generate fluorescence that are collected 
by photomultipliers (upto 4 at the moment) that transform the optic to 
electric signal, then cytometer send all information to the computer system 
for later analysis.(FACS facility). 
Fluorescence-activated cell sorting is a specialized type of flow 
cytometry. It provides a method for sorting a heterogenous mixture of 
biological cells into two or more containers, one cell at a time, based upon 
the specific light scattering and fluorescent characteristics of each cell. It 
provides quantitative recording of fluorescent signals from individual cells 
as well as physical separation of cells of interest. 
CD4 cell count is extremely important in the staging of HIV infection 
and revised classification of the Center of Disease Control divides HIV 
positive patients into three categories. 
CDC CLASSIFICATION SYSTEM OF HIV INFECTION 
CD4+ T-cell 
count (cells/µL.) 
(CD4%) 
Asymptomatic, 
acute (primary) 
HIV or PGL 
Symptomatic, 
not A or C 
conditions 
AIDS-indicator 
conditions 
>500 (28%) A1 B1 C1 
200-499(15-
28%) 
A2 B2 C2 
<200(14%) A3 B3 C3 
 
Category A: Asymptomatic HIV infection, persistent generalized 
lymphadenopathy (PGL). 
Category B: Oropharyngeal and Vulvovaginal candidiasis, constitutional 
symptoms such as fever (38.5 C) or diarrhea lasting >1 month, herpes zoster 
(shingles). 
Category C: Mycobacterium tuberculosis (pulmonary and disseminated),  
Pneumocystis carinii pneumonia, candidiasis of bronchi; trachea or lungs, 
extrapulmonary cryptococcosis, CMV, HIV-related encephalopathy, 
Kaposi’s sarcoma, wasting syndrome due to HIV. 
When the number of CD4+ T cells declines below a certain level, the patient 
is at high risk of developing a variety of opportunistic diseases, particularly 
the infections and neoplasms that are AIDS defining illness. 
Opportunistic infections in HIV patients 
Bacterial Infections 
• Bacterial Diarrhea 
• Bacterial Pneumonia 
• Mycobacterium Avium Complex 
           (MAC) 
• Mycobacterium Kansasii 
• Syphilis and Neurosyphilis 
• Tuberculosis 
Fungal Infections 
• Candidiasis 
• Aspergillosis 
• Coccidioidomycosis 
• Cryptococcal Meningitis 
• Hisoplasmosis 
Protozoal Infections 
• Cryptosporidiosis 
Malignancies 
• Anal Dysplasia/Cancer 
• Cervical Dysplasia/Cancer 
• Kaposi’s Sarcoma, Lymphomas 
• Isospoirasis 
• Microsporidiosis 
• Toxoplasmosis 
 
Viral Infections 
• Cytomegalovirus (CMV) 
• Hepatitis C 
• Herpes Simplex Virus (oral & 
             genital herpes)  
• Herpes Zoster Virus(shingles) 
• Human Papilloma Virus 
(HPV, genital warts, anal / cervical 
dysplasia/ cancer) 
• Molluscum Contagiosum 
• Oral Hairy Leukoplakia 
(OHL) 
• Progressive Multifocal 
Leukoencephalopathy 
 
Neurological Conditions 
• AIDS Dementia Complex 
• Peripheral Neuropathy 
        Others 
• Aphthous Ulcers 
• Thrombocytopenia 
• Wasting Syndrome 
 
BLOOD STREAM INFECTIONS 
 The invasion of the bloodstream by microorganisms constitutes one of 
the most serious situations in infectious disease and can have immediate 
consequences including shock, multiple organ failure, disseminated 
intravascular coagulation (DIC) and death. Pathogens of all the four major 
groups of microbes- bacteria, fungi, viruses, parasites- may be found 
circulating in the blood during the course of many diseases8. 
TYPES OF BLOOD STREAM INFECTIONS  
 The two major categories of bloodstream infections are intravascular 
(those that originate within the cardiovascular system) and extravascular 
(those that result from bacteria entering the blood circulation through the 
lymphatic system from another site of infection). Of note, other organisms 
such as fungi, may also cause intravascular or extravascular infections. 
However, because bacteria account for the majority of significant vascular 
infections, these types of blood stream infections are addressed8. 
INTRAVASCULAR INFECTIONS 
 Intravascular infections include infective endocarditis, mycotic 
aneurysm, suppurative thrombophlebitis, and intraveneous (IV), catheter 
associated bacteremia. These infections in the cardiovascular system are 
extremely serious and are considered life- threatening. 
 
EXTRAVASCULAR INFECTIONS 
Except for intravascular infections, bacteria usually enter the circulation 
through the lymphatic system. Most cases of clinically significant bacteremia 
are a result of extravascular infection.  
 The most common portals of entry for bacteria are the genitourinary 
tract     (25%), respiratory tract (20%), abscesses (10%), surgical wound 
infections (5%), biliary tract (5%), miscellaneous sites (10%) and uncertain 
sites (25%). For the most part, the probability of bacteremia occurring from 
extravascular site is dependant on the site of infection, its severity, and the 
organisms including members of the family Enterobacteriaceae, 
Streptococcus pneumonia, Staphylococcus aureus, Neisseria gonorrhoeae, 
anaerobic cocci, Bacteroides, Clostridium, beta-hemolytic streptococci, and 
Pseudomonas8.  
A bacteremia or BSI is called primary if the point of entry or focus 
cannot be determined, or if it originates from an intravascular catheter 
(catheter related BSI).  
Renaud and Brun- Buisson in 2001 in their recent studies, have 
recommended differentiating catheter -related bacteremia from both primary 
and secondary bacteremia. If a distant site other than an IV catheter can be 
established as the point of origin, BSI is referred to as secondary27. 
Another way to classify BSI is by the time or setting of acquisition, 
i.e. community acquired or nosocomial BSI. 
  A recent study by Siegman-Igra et al  proposed to classify BSIs as 
follows : true community - acquired BSI (detected within 48h after 
admission in patients who have not been hospitalized within past 30 days 
and did not have a recent history of invasive procedures), BSI in recently 
discharged patients (2-30 days prior to the recent episode of BSI), BSI in 
patients with recent history of invasive procedures (including insertion of  
Foley catheters, placement of intravascular catheters, long term devices, 
central venous catheters, or dialysis), nursing home acquired bacteremia and 
true  nosocomial BSI (detected  > 48h after admission)27. 
PREDISPOSING FACTORS 
 Factors that contribute to the initiation of blood stream infections are 
immunosuppression, widespread use of broad spectrum antibiotics that 
suppress the normal flora and allow the emergence of resistant strains of 
microbes, invasive procedures that allow bacteria access to interior of the 
host, more extensive surgical procedures, and prolonged survival of 
debilitated and seriously ill patients8. 
PATHOGENESIS AND CLINICAL PRESENTATION 
Clinical presentation ranges from benign transient bacteremia with 
little or no symptoms to fulminant septic shock with high mortality. 
Transient bacteremia may follow manipulation of or surgery in infected or 
colonized areas. Intermittent bacteremia is usually seen secondary to 
abscesses, mostly abdominal or pelvic. Continuous bacteremia is associated 
with endocarditis or other intravascular infections, but may also occur in the 
first weeks of typhoid fever or brucellosis59. In patients with 
intermittent and continuous bacteremia, fever is the most common symptom 
followed by other unspecific signs of systemic disease, such as elevated 
heart and respiratory rate, fatigue, malaise, or failure to thrive in neonates. A 
substantial proportion of patients with infection may also be euthermic or 
hypothermic27. 
BLOOD STREAM INFECTIONS AND HIV 
Bloodstream Infections (BSIs) have been a significant cause of 
morbidity and mortality in patients infected with the human 
immunodeficiency virus (HIV) 21, 22, 33, 40, 49, 58, 60, 70. With the introduction of 
new antiretroviral agents and therapeutic strategies in recent years, the 
management of HIV-infected patients has changed profoundly. The 
availability of highly active antiretroviral therapy (HAART) that is capable 
of effectively suppressing viral replication has improved the prognosis for 
many HIV-infected patients over prolonged periods of time. Moreover, the 
use of combination antiretroviral therapy has been associated with a decline 
in the incidence of opportunistic infections11,31. 
 Several conditions have been considered to predispose to the 
development of bloodstream infections in HIV-infected patients. In 
particular, defective cell-mediated immunity, altered B-cell function with 
consequent lack of serum opsonins against certain capsulated bacteria, and 
qualitative and quantitative deficits of neutrophils are probably the most 
common conditions associated with the increased incidence of bloodstream 
infections in HIV-infected patients.  
Traditional risk factors for nosocomial bloodstream infections, such as 
use of invasive devices, exposure to antibiotics and duration of hospital 
stays, also apply to patients with HIV infection. However, the relative 
contribution of immunosuppression, treatment, and prevention of HIV-
related opportunistic infections as risk factors for nosocomial bloodstream 
infection still remain to be defined43,75. There were no other important 
differences, including no difference in mortality when compared preHAART 
and HAART era40. 
PATHOGENS 
 Almost any pathogen isolated from the bloodstream as a causative 
agent of clinically significant bacteremia, fungemia or BSI, especially in a 
immunocompromised patients. The spectrum of pathogens has changed 
considerably over the last decades. 
In recent studies of Edmond et al. 1999; Diekema et al. 2003; 
Wisplinghoff et al. 2004 showed, about 13% of all episodes were 
polymicrobial, 60-65% were caused by gram positive and 25-31 percent by 
gram negative organisms. Fungi, mainly Candida species, were isolated 
from 7-10% of episodes. Anaerobic bacteria accounted for about 1percent of 
BSI). The most common pathogens isolated from BSI are Coagulase 
negative staphylococci, Staphylococcus aureus, Enterococci, Candida spp., 
E.coli, Klebsiella spp., P.aeruginosa, Enterobacter spp., Serratia spp., 
A.baumanni27. 
GRAM POSITIVE ORGANISMS 
Staphylococcus aureus 
S.aureus is a major cause of morbidity and mortality. Commonly 
isolated from patients with both community-acquired and nosocomial BSI 
usually originates from a localized infection, an intravascular catheter or a 
contaminated syringe (e.g. in IV drug users). Methicillin resistance, first 
detected in the 1960s (Barber 1961), emerged as a major clinical and 
epidemiological problem in hospitals in the 1980s.  
Studies by Frank et al., Fergie and Purcell, Groom et al., Naimi et al., 
and Baggett et al. showed that, even though MRSA has been a nosocomial 
pathogen, there are an increasing number of reports of MRSA BSI in 
patients with little or no association to the healthcare systems, suggesting the 
emergence of true community-acquired MRSA.  
Small colony variants (SCV), a naturally occurring subpopulation of 
S.aureus have also been identified as a cause of BSI (Seifert et al. 2003b). 
S.aureus SCVs have been implicated in persistent and recurrent infections 
that give a poor clinical and bacteriological response to standard 
antimicrobial therapy in patients with BSI, chronic osteomyelitis, cystic 
fibrosis, and AIDS particularly after prolonged exposure to antibiotics ( von 
Eiff et al. 1997; Kahl et al. 1998; Proctor et al. 1998)27. 
Coagulase-negative staphylococci 
 BSI caused by Coagulase –negative staphylococci is mostly 
nosocomial, but about 8% have also been community acquired (Diekema et 
al. 2003). CoNS were being reported from cases only if isolated from two or 
more separate blood cultures.  S.epidermidis is the most commonly isolated 
species among CoNS, others implicated in BSI includes S.haemolyticus, 
S.capitis, S.lugdunensis, S.saprophyticus, S.schleiferi, S.simulans and 
S.warneri27.  
Enterococcus species 
Primary BSIs are generally seen in highly compromised or 
immunosuppressed patients and may be due to inapparent bacterial 
translocation from a gastrointestinal source (Shlaes et al. 1981b; Graninger 
and Ragette 1992; Linden et al.1996) or intravascular catheters27. 
Other gram –positive organisms 
 Streptococcus pneumonia, S. viridans, Listeria monocytogenes, and 
Diphtheroids. 
GRAM-NEGATIVE ORGANISMS 
Escherichia coli and other Enterobacteriaceae 
Enterobacteriaceae are important causes of both community acquired 
and nosocomial infections including BSI, accounting for 17 percent of all 
BSI, making them the second most common cause of BSI after CoNS.  
E.coli accounts for 7-11% of nosocomial BSI to date (Pittet and Wenzel 
1995; Edmond et al. 1999; Wisplinghoff et al.2004), Klebsiella spp. causes 
about 10 percent of community acquired BSI and about 6 percent of 
nosocomial BSI. Non-typhoid Salmonella species have been described as 
etiological agents of community acquired BSI in both immunocompromised 
and previously healthy patients27.  
Pseudomonas aeruginosa 
P.aeruginosa BSI is mainly nosocomial, contributing significantly to 
morbidity and mortality of hospitalized patients. Nosocomial pneumonia due 
to P.aeruginosa is often associated with BSI in adult and pediatric AIDS 
patients; the prognosis is poor with fulminant progression to septic shock 
and death occurring within 3-4 days after the onset of pulmonary 
symptoms27. 
Other gram-negative pathogens 
Acinetobacter baumannii, Haemophilus influenza, Neisseria species 
FUNGI 
Blood cultures are an important tool in the diagnosis of disseminated 
fungal infections. Lysis centrifugation system appears to be more sensitive 
method for detection of filamentous fungi as well as Histoplasma 
capsulatum and other dimorphic fungi. Candida species, particularly 
C.albicans are frequently isolated from the blood stream, accounting for up 
to 10 percent of all nosocomial blood culture isolates and is usually 
associated with underlying conditions such as malignancies, neutropenia, 
HIV/AIDS27. 
LABORATORY DIAGNOSIS OF BLOOD STREAM INFECTIONS 
 Blood cultures are valuable diagnostic tool and should be considered 
in an broader range of situations in compromised patients with underlying 
conditions that predispose for BSI27. Bacterial growth can be detected using 
techniques ranging from manual to totally automated methods. Once growth 
is isolated, identified, and tested for its susceptibility to various antimicrobial 
agents when appropriate8. 
 
SPECIMEN COLLECTION AND TRANSPORT 
 The blood culture denotes a specific volume of blood which is 
aseptically drawn by a single venipuncture, inoculated into culture medium 
or media and investigated for the presence of microorganisms. Obtaining 
blood cultures from indwelling intravascular catheters is generally not 
recommended, unless the involvement of the catheter as a source of BSI is to 
be investigated27. 
SPECIMEN COLLECTION 
 Since the rapid and reliable recovery of even small numbers of 
bacteria from the blood is the primary goal of blood cultures, the media also 
provide excellent growth conditions for contaminants and contamination 
poses a serious problem. In addition, an increasing number of true 
bacteremia and BSI in immunocompromised patients is caused by bacteria 
that are part of the common skin flora, such as coagulase negative 
staphylococci, corynebacteria, and Bacillus species. Correct interpretation of 
such findings largely depends on the assumption that proper aseptic 
techniques have been used for specimen collection and transport. 
COLLECTION SITE 
 Usually blood for culture is drawn from a peripheral vein, e.g. vena 
cubitalis. Contamination is more likely if femoral vein or a vein in close 
proximity to an inflammation or skin infection site is used (Washington 
1975). Arterial blood does not offer any advantage with regard to detection 
of pathogens, not even for endocarditis or fungemia (Tenney et al. 1982; 
Vaisanen et al. 1985). The reliability and diagnostic impact of blood cultures 
drawn through an intravascular catheter is controversial (Tonnesen et 
al.1976; Bryant and Strand 1987). Contamination rates are higher and 
catheters may be colonized with organisms that do not necessarily invade the 
blood stream. However blood from the source, even via different lumens of 
the catheter, may be used in conjunction with peripheral blood samples to 
assess the presence of a catheter related BSI27. 
ANTISEPSIS 
 Once a vein is selected, the skin site is disinfected with 70% isopropyl 
alcohol in a circle approximately 5cm in diameter, rubbing vigorously. 
Starting from the centre of the circle, 2% tincture of iodine (or povidone-
iodine) in ever widening circles until the site is saturated with iodine and 
allowed to dry on the skin for at least 1 minute. Gloves should be worn by 
the phlebotomist42. 
TIME OF COLLECTION  
To obtain the maximum yield of organisms, blood should be collected 
immediately before the onset of chills. It is generally recommended to draw 
blood for culture when the patient’s temperature rises, as soon as possible 
after the onset of fever and chills. Whenever possible, blood cultures should 
be obtained before antimicrobial chemotherapy is initiated. If a patient is 
already receiving antimicrobials, blood cultures should be drawn towards the 
end of a dosing interval42. 
SPECIMEN VOLUME 
Adults. Most bacteremias in adults have a low number of colony 
forming units (CFU) per milliliter of blood. Therefore a sufficient sample 
volume is critical for the successful detection of bacteremia35. The greater 
the chance of isolating the organism, when more blood is cultured; findings 
from a study suggested that the yield increases by 3.2% for each milliliter of 
blood cultured42. Therefore, collection of 10-20mL of blood per culture is 
strongly recommended for adults. Volumes of 20 mL increased the yield by 
30% compared with 10mL volumes18. 
 Children. It is not safe to obtain large volumes of blood from 
children, particularly infants; in light of low level of bacteremia in infants 
and children and based on the premise that it is safe to obtain as much as 4% 
to 4.5% of a patients known blood volume for culture and on the known 
relationship between blood volumes for culture from infants and children 
(Table 1) have been made by Baron and colleagues6. 
 
 
 
Table 1 Blood Volumes Suggested for Cultures from Infants and Children 
Weight of 
patient 
Recommended volume of blood for culture (mL) 
Kg Total 
blood 
volume 
Culture  
No 1 
Culture  
No 2 
Total 
volume 
for 
culture 
% of total 
blood 
volume 
≤1 50-99 2  2 4 
1.1-2 100-200 2 2 4 4 
2.1-12.7 >200 4 2 6 3 
12.8-36.3 >800 10 10 20 2.5 
>36.3 >2200 20-30 20-30 40-60 1.8-2.7 
 
NUMBER OF BLOOD CULTURES 
 The detection rate increases with the number of blood cultures 
obtained. In patients with BSI found 99 percent sensitivity if only two 
cultures were drawn4, 30, 46, 67, 69. There is currently no recommendation for an 
optimal time difference between the first and the second culture12. 
CULTURE MEDIA 
 Depending on the indication, the patient, and the suspected pathogen, 
the use of special culture media or a different number of bottles per blood 
culture may be useful. Nutrient rich broth in a variety of formulations can be 
used to culture microorganisms from the blood. These include brain-heart 
infusion broth (BHI), tryptic –soy-broth (TSB), soybean casein digest broth, 
peptone broth and Columbia media, which may be supplemented with 
haemin or NADH8. Microbial growth in human blood is inhibited by a 
number of substances including antibodies, leukocytes, complement, 
lysozyme, and antimicrobial substances, which about one third of patients 
already receive, when blood cultures are obtained (Weinstein et al. 1997). 
Blood clots also reduce the diagnostic yield, thus blood drawn for culture 
may be either inoculated into the blood culture broth media or sterile blood 
culture bottle containing an anticoagulant. 
Sodium polyanethol sulfonate (SPS, Liquoid) (Wilson et al. 1994), in 
concentrations of 0.025% to 0.03% is the best anticoagulant for blood, also 
inhibits lysozomal activity, complement and phagocytosis (Traub and Kleber 
1977; Chandrasekar and Brown 1994)66. Also 1:5 to 1:10 dilutions of blood 
enhances detection by neutralizing the bactericidal activity of human serum8  
and by diluting antimicrobial agents to sub inhibitory concentrations. 
 Aminoglycosides and polymyxins are also inhibited by SPS. Side effects of 
SPS include some inhibition of the growth of Neisseria gonorrhea, Neisseria 
meningitides, Gardenella vaginalis, Peptostreptococcus anaerobius and 
Moraxella catarrhalis. Antimicrobial agents can also be neutralized b y 
adding unspecific adsorbants such as antimicrobial disease(ARD) (Peterson 
et al. 1983), antibiotic binding resins on glass beads (BACTEC) ( BD, 
Sparks, MD), or activated charcoal and Fuller’s earth ( Ecosorb, 
BacT/ALERT, BioMerieux Inc., Durham, NC).  
TRANSPORT  
Rapid transport of blood cultures to the microbiology laboratory is 
mandatory. Refrigeration of blood cultures should be avoided. In the 
laboratory, all blood cultures should be processed immediately68. 
SAMPLE PROCESSING 
 In patients with BSI, the appropriateness of antimicrobial 
chemotherapy is correlated with survival (Ibrahim et al.2000). Processing of 
blood cultures generally includes incubation, gram staining and subcultures. 
Manual processing and automated blood culture systems are used.  
CONVENTIONAL BLOOD CULTURES 
All manual processing should be done under a protective hood, both to 
avoid contamination and to protect laboratory personnel. All blood cultures 
should be incubated for at least 6-18h at 36±1°C before processing. 
Afterwards blind subcultures and microscopic examination of all aerobic 
cultures should be performed, using approximately 0.2 mL of broth, which 
should be removed under sterile aseptic precautions after gentle shaking.  
For microscopic examination, Gram or acridine-orange stains can be 
performed. While acridine orange stains detected 104CFU/mL, Gram stain 
detected only 105 CFU/mL (Seifert et al.1997).  
Blood agar, chocolate agar and some differential media (e.g. 
MacConkey) should be used for subculture of blood and subsequently 
incubated at 36±1°C in an aerobic atmosphere with 5- 10 % CO2. Also if 
signs of turbidity, change of color, or gas production are detected, the 
respective culture bottle must be processed8.  
Blood cultures do not need to be routinely incubated for more than 7 
days for suspected bacterial cultures42. Fungal blood cultures were held for 
21 days before being reported as negative59. 
LYSIS CENTRIFUGATION SYSTEM 
 Lysis centrifugation system commercially available is the Isolator 
(Wampole Laboratories, Cranbury, NJ). The Isolator consists of a stoppered 
tube containing saponin to lyse blood cells, polypropylene glycol to decrease 
foaming, SPS as an anticoagulant, EDTA to chelate calcium ions and thus 
inhibit complement cascade and coagulation and a small amount of an inert 
fluorochemical (Fluorinet, 3M Co., St. Paul, Minn) to cushion and 
concentrate the microorganisms during 30minute centrifugation, the 
supernatant is discarded, the sediment containing the pathogen is vigorously 
vortexed, and the entire sediment is plated to solid agar8. 
AUTOMATED CULTURE SYSTEMS 
 The first automated blood culture system, BACTEC 460 (Becton 
Dickinson), was introduced in the 1970s. The use of automated blood culture 
systems rapidly increased after the introduction of continuous monitoring 
blood culture systems in the early 1990s. In all systems cultures are 
monitored at intervals between 10 and 24 min, 24 h per day, shortening time 
to detection by 1-1.5 days53. 
BACTEC Systems  
 The BACTEC system measures the production of carbon dioxide 
(CO2) by metabolizing organisms. While the first BACTEC systems used 
14C labeled substrates, the newer BACTEC 9000 series use fluorescence 
sensing mechanism 63. 
BacT/ALERT Microbial detection system: 
 BacT/ ALERT (BioMerieux, Durham, NC), measures CO2 derived pH 
changes by a colorimetric sensor in the bottom of each bottle. The sensor is 
separated from the broth medium by a membrane that is permeable only to 
CO2. As the organisms grow, they release CO2, which diffuses across the 
membrane and is dissolved in water present in the matrix of the sensor. As 
CO2 is dissolved hydrogen ions are generated which cause color change in 
the sensor (blue to light green to yellow as the pH decreases); this color 
change is read by the instrument. 
ESP system 
 In ESP culture system II (Trek Diagnostic systems, Inc., Cleveland, 
Ohio),microbial growth is detected by monitoring changes in head space 
pressure by a sensitive detector that is attached to the blood culture bottles, 
by  consumption and/or production of gases as organisms metabolize 
nutrients in the culture medium. 
HANDLING POSITIVE BLOOD CULTURES  
 All clinically significant isolates should be identified to species level 
with biochemical reactions or by rapid identification systems. 
 ANTIMICROBIAL SUSCEPTIBILITY TESTING: 
In a recent study by Ibrahim et al., mortality was double when 
inappropriate empirical antibiotics were administered to patients with BSI. 
Therefore successful management must include early and appropriate 
antimicrobial therapy in addition to supportive care and elimination of a 
removable focus, if present. 
ANTIBACTERIAL SUSCEPTIBILITY TESTING: 
Antibiotic sensitivity testing was performed by the Kirby-Bauer disc 
diffusion technique, using 0.5 McFarland’s turbidity as the standard 
inoculum’s density on Mueller Hinton agar plates. Commercial Hi-Media 
antibiotic discs were used. 
ANTIFUNGAL SUSCEPTIBILITY TESTING: 
The recent increased incidence of fungal infections and the growing 
number of new antifungal agents have multiplied the demand and interest for 
invitro antifungal susceptibility testing. 
MANAGEMENT OF BSI 
 Le and Bayer et al recently reviewed the general treatment principles 
to be followed: 1) high dose parenteral antimicrobial therapy is 
recommended to reach sustained antibacterial activity; 2) prolonged 
administration of antimicrobial therapy is necessary to prevent relapse; 3) 
bactericidal antimicrobial agents are generally preferred over bacteriostatic 
agents; 4) antibiotic combination therapy is recommended to produce a rapid 
bactericidal effect. The choice of antibiotics for the treatment is governed by 
the susceptibility of the causative organism. Determination of minimal 
inhibitory concentration is recommended to define optimal treatment.                                  
          
 
 
 
 
 
 
 
 
 
                                                                                                                            
                                                                                                                                                                                        
MATERIALS AND METHODS 
STUDY PERIOD  
This is a cross sectional study undertaken over period of June 2009 – 
May 2010 
STUDY PLACE 
This study was carried out at the Institute of Microbiology, Madras 
Medical College, Chennai and Antiretroviral therapy (ART) centre, Madras 
Medical College, and Government General Hospital, Chennai. 
ETHICAL CONSIDERATIONS 
This study was reviewed and approved by Institutional Ethical 
committee, Madras Medical College & General Hospital, Chennai 3. 
Informed written consent to participate in the study was obtained from the 
patients or their guardians after providing full explanation of the study. All 
data were handled confidentially and anonymously. 
STATISTICAL ANALYSIS 
Statistical analyses were carried out using Statistical Package for 
Social Sciences (SPSS) and Epi-Info softwares by a statistician. The 
proportional data of this cross sectional study were tested using Pearson’s 
Chi Square analysis test and Binomial proportion test. 
 
 
STUDY GROUP 
Cases: 
Study group includes 100 HIV positive adult inpatients irrespective of 
the symptomatology, CD4 count and ART status. 
Inclusion Criteria 
1. HIV positive patients: Seropositivity status of the patients was 
determined as per NACO guidelines. 
2. Patients above 15 years of age group (For the purposes of HIV case 
definitions for reporting and surveillance, children are defined as 
younger than 15 years of age and adults as 15 years or older)71. 
3. Both Males and Female were included in the study. 
All patients satisfying the inclusion c riteria were only once 
documented and were assigned serial numbers. Patients were interviewed by 
structured questionnaire and their hospital records were used to know about 
their past medical conditions. They were prospectively followed up until 
discharged or 30 days after admission. 
Controls: 
 Control group includes 50 patients, seronegative for HIV admitted as 
inpatients, irrespective of the symptomatology. 
 
 
Case Definition 
Bacteremia or blood stream infection (BSI) was diagnosed when a blood 
culture grew an organism with (secondary BSI) or without (primary BSI) 
any obvious focus of sepsis. True bacteremia was considered when one or 
more blood cultures showed a recognized pathogen.) . 
Community-acquired bacteremia was defined if the first positive blood 
culture was obtained before or within 48 hours of hospitalization. 
Nosocomial bloodstream infections were considered, if signs and 
symptoms of these infections became evident >48 hours following hospital 
admission and/or if the patient had been hospitalized during the 2 weeks 
before the current admission. 
The source of bacteremia was identified by the isolation of the same 
pathogenic organism from both the source and the blood. 
  The following definitions were used to categorize the source of the 
patients’ bacteremia.  
Pneumonia was defined as the presence of an acute illness with respiratory 
symptoms and an infiltrate on chest roentgenography.  
Cellulitis required the physical finding of an erythema, tenderness, and 
warmth in a focal distribution.  
Phlebitis was defined as an inflammation around a venous line site, a 
positive line culture or a catheter in place at least 72 hours and the absence of 
another source of bacteremia. 
 Endocarditis was defined as the demonstration of valvular vegetations on 
echocardiography, evidence of septic emboli or a new murmur, and the 
absence of another source of bacteremia. 
A urinary tract infection required a positive urine culture result and no 
other source of the bacteremia.  
Catheter- related blood stream infection (CRBSI) was diagnosed when 
blood culture from a peripheral vein and CVC grew an organism and the 
CVC tip with quantitative bacterial counts >15 CFU (Maki method). 
DATA COLLECTION 
All patients underwent history and physical examination. Information 
on antimicrobial therapy before admission was recorded. The stage of HIV 
infection was recorded using the WHO Clinical Staging System74. 
SPECIMEN COLLECTION 
Blood cultures were obtained using aseptic technique. Venipuncture 
sites were disinfected before phlebotomy with 0.5% chlorhexidine solution 
followed by 70% isopropyl alcohol72.  
For the purpose of the culture, 10 ml of blood was drawn, and was 
used to inoculate biphasic brain-heart infusion (BHI) bottles and trypticase 
soy medium. 
For estimation of CD4 counts, 3 ml of blood collected in EDTA 
containing vacutainers, Counting done using BD FACS Counter. Peripheral 
smears were also made from blood samples for evaluation of parasites: 
Plasmodium and Microfilaria. 
Blood culture bottles were incubated at 37° C for 24 hours. 
Subcultures were done at the appearance of turbidity, gas production or the 
presence of microcolonies over the clot at 24 hours, blind subcultures at 48 
hrs irrespective of turbidity or gas production  and final subcultures were 
done at the end of 7th day, as follows:  a) on 5% sheep Blood Agar 
aerobically. 
         b) On 5% Blood Agar Anaerobically, 
         c) On MacConkey Agar Aerobically, 
         d) Nutrient Agar 
         e) On Chocolate Agar in CO2, all incubated at 37°C for 24 hours & 
         f)  2 Sabouraud Dextrose Agar tubes incubated at 25°C and 37°C. 
CULTURE IDENTIFICATION 
Colony morphology on blood agar, MacConkey agar, chocolate agar 
at 18-24 hours were noted and isolates were identified by 
1. Gram stain- to identify Gram positive and Gram negative organisms. 
2. Gram-positive cocci were proceeded with catalase and coagulase tests. 
3. Hanging drop- to find out motile and non motile organisms.  
4. Preliminary tests like Oxidase, Catalase were performed. 
5. Members of the species were identified based on biochemical parameters 
using IMViC reaction and sugar fermentation medium.   
ANTIMICROBIAL SUSCEPTIBILITY TESTS: 
Antimicrobial susceptibility of the isolates were tested using Kirby Bauer 
disc diffusion technique as per CLSI guidelines16. 
Medium used: MHA (Muller Hinton Blood agar plate) 
Inoculum: 0.5McFarland turbidity, lawn Culture. 
Incubation: 37˚C ambient air, incubated for 16-18 hrs 
Preparation of inoculums: 
About 4-5 colonies of the same morphology were picked up with 
straight wire and inoculated in 5ml of peptone water, incubated at 37°C for 
3-5 hrs to attain 0.5 McFarland’s turbidity8. A sterile cotton swab was dipped 
into it and pressed firmly against the wall of the test tube to remove excess 
broth from the swab. 
Dried surface of Mueller Hinton Agar plate was swabbed in three 
directions approximately 60° each time to ensure an even and complete 
distribution of the inoculum over the entire plate. The anti microbial discs 
were dispensed on the agar plate and pressed down to ensure complete 
contact with agar surface. Discs were distributed evenly so that they were 
not closer than 24mm from centre to centre. Not more than 6 discs were 
placed in the plate32. After 16-18 hrs of incubation each plate was examined. 
The diameter of the zones of complete inhibition was measured including the 
diameter of the discs. Zones were measured to the nearest whole ‘mm’ using 
a ruler which was held on the back of the inverted Petri plate. 
Control strains used were  
1. Staphylococcus aureus ATCC 25923 
2. Escherichia coli ATCC25922 
3. Pseudomonas aeruginosa ATCC 29823 
Growth in Sabourauds Dextrose Agar is subjected for following tests: 
The Sabourauds dextrose agar slopes were examined after 48hrs, 96 hrs, 
5days, 7days, 14days and one month for the appearance of yeasty or mouldy 
growth34. 
GRAM STAIN 
Gram positive oval budding yeasts cells with presence or absence of 
pseudohyphae 
 
 
 
INDIA INK PREPARATION 
 A loopful of creamy colonies from SDA was taken and mixed with a 
drop of India Ink over a slide. Coverslip is applied over it and focused under 
high power objective to see budding yeast cells with capsule. 
GERM TUBE TEST 
A loopful of creamy white yeast like colony from SDA was taken and 
it was inoculated in to 0.5ml of mammalian serum. It was incubated at 37 
degree centigrade for one and a half to 2 hours. After incubation period, a 
loop full of this serum suspension was placed on a clean glass slide and 
covered with cover slip and focused under high power objective to see the 
characteristic germ tube formation. 
CHROM AGAR (HIMEDIA) 
A single colony from Sabourauds dextrose agar was taken and it was 
streaked on chrom agar and incubated at 37°C for 48 hrs. After incubation 
period the plates were observed for characteristic coloured colonies of 
candida. 
CORNMEAL AGAR 
A single colony from Sabouraud’s dextrose agar was inoculated on to 
plate of cornmeal agar containing 1%Tween 80 and trypan blue. Three 
parallel steaks were made about half an inch apart at a 45 degree angle to the 
culture medium. A sterile coverslip was placed over it and incubated at 30 
degree centigrade for 48 hrs. After incubation the areas where the cuts into 
the agar36 were made were examined for the presence of blastoconidia, 
arthroconidia, pseudohyphae, hyphae or chlamydoconidia8. 
ANTIFUNGAL SUSCEPTIBILITY TESTS: 
The antifungal susceptibility tests was done by two methods 
1) DISC DIFFUSION METHOD 
2) BROTH MICRODILUTION METHOD 
Inoculum preparation: 
The inoculum suspension was prepared by picking five colonies, each 
of atleast 1mm in diameter, from 24 hour old cultures of candida species and 
suspending the material in 5ml of sterile saline. The suspension was then 
adjusted spectrophotometrically at 530nm to match the transmittance 
produced by 0.5 McFarland’s barium sulphate standard. This procedure 
produces an inoculums size 1×106  to 5×106 CFU/ml. The same inoculum 
was used for both methods. 
The following standard strain was tested each time to ensure quality 
control: 
Candida albicans ATCC 90028 
Disc diffusion method 
It was performed on Muller Hinton agar plate supplemented with 2% 
glucose and 0.5μg/ml methylene blue17. Antifungal susceptibility testing was 
carried out following the M 44-A. National Committee for Clinical 
Laboratory Standards (NCCLS) guidelines, using fluconazole and 
itraconazole antifungal discs37. 
Enumeration of CD4 + T cells 
 Estimation of CD4+ T lymphocyte of the HIV infected patients was done by 
Fluorescent Activated Cell Sorter (FACS) count system. 
• Blood sample was collected aseptically in a K3 EDTA Vacutainer tube. 
• 50μl of whole blood was added to the reagent tube containing 
fluorescent labelled antibodies which results in the binding of labelled 
monoclonal antibodies to the lymphocyte surface antigen. 
• After adding fixative solution to the reagent tube, the sample was run 
in the instrument38. 
• The cell comes in contact with the laser beam which causes the 
fluorochrome labelled antibodies to fluoresce. 
• The fluorescent light provides the information necessary for the 
instrument to count the cells. 
• The software identifies the T- lymphocyte subpopulation and correlates 
with the absolute count 
• Results provide the absolute counts of CD4+ lymphocyte19. 
 
PERIPHERAL SMEAR EXAMINATION FOR MALARIAL 
PARASITES 
  Peripheral smear examination for malarial parasite is the gold-standard 
in confirming the diagnosis of malaria. Thick and thin smears prepared from 
the peripheral blood are used for the purpose. 
PREPARATION OF THE SMEAR13, 65 
Thin Smear 
• One end of the slide is allowed to touch the top of the blood drop on 
the patient’s finger.  
• Only the top of the drop should come into contact with the slide.  
• The quantity of blood to be transferred to the slide should not exceed 
1.5 ml, usually corresponding to a diameter of 3-4 mm.  
• The edge of a second slide (or a cover slip) is then laid on the drop of 
blood that will spread on the entire line of contact between the two 
slides.  
• The second slide, steadily held to form a 45° angle with the original 
slide, is then moved to the opposite end of the slide to which the drop 
was originally located.  
• In the well prepared thin film, the blood film should end with multiple 
tails not touching the edges of the slide.  
• Red blood cells should be visible one by one without 
overlapping.Abnormally thick slide may be the result of an 
exaggerated volume of blood or of an angle larger than 45°. 
Thick smear  
• A volume of blood twice to thrice the one used for a good thin film is  
needed for the preparation of a thick film (3.0 to 4.0 ml).  This is 
usually accomplished by touching three times the top of the blood 
drop at the top of the finger to obtain a triangle on the slide.  
• The blood is then gently mixed for 20-30” using the corner of a 
second slide to defibrinate the blood and to obtain a round smear of 
about 1 cm in diameter.  
• The thickness of the obtained film should allow the reading of the 
printed  text of a usual newspaper through it (Gilles, 1993) 
Staining:  
  Thick films are ideally stained by the Giemsa’s stain for screening of 
parasites. Thin blood films stained by Giemsa’s or Leishman’s stain are 
useful for specification of parasites  
PROCEDURE 
The thick film was first de-hemoglobinised in water and then stained 
with Giemsa. 
 
Rapid Giemsa:  
• Prepared a 10% Giemsa in buffered water at pH 7.1.  
• Immersed the slide in the stain for 5 minutes.  
• Rinsed gently for 1 or 2 seconds in a jar of tap water. 
• Drained, dried and examined. 
Thin film was stained with Leishman’s stain. 
Leishman's stain:  
• Added 7-8 drops of the stain and left for 1-2 minutes.  
• Then added 12-15 drops of buffered distilled water, mixed 
thoroughly, left for 4 - 8 minutes.  
• Then washed off with clean water, drained, dried and examined. 
INTERPRETATION OF RESULTS 
A culture was considered significant when a pure isolate was isolated 
from a pair of blood culture bottles. Samples that showed no growth in BHI 
media and media were discarded after 7days. Fungal blood cultures were 
held for 21 days before being reported as negative. Blood isolates of 
Staphylococcus spp. were considered to be contaminated if a single blood 
culture yielded the organisms, if the clinicians judged the organisms to be 
contaminants, and if antibiotic therapy directed against these organisms was 
not administered. 
 
RESULTS 
A total of 150 individuals were enrolled in this study, conducted 
during May 2009 to May 2010 at Institute of Microbiology, Madras Medical 
College, Chennai. It included 100 HIV seropositive cases and 50 HIV 
seronegative individuals as controls, determined by HIV antibody detection 
methods. Blood samples collected from all the subjects were subjected to 
culture in Brain Heart Infusion Biphasic medium and Trypticase Soy broth. 
Peripheral smear was stained by Leishmann staining and enumeration of 
CD4 counts were done. Results were analyzed further as follows: 
 
TABLE 2: DESCRIPTION OF STUDY GROUPS 
Study Group Description Number of 
individuals 
Cases  HIV seropositive patients 
with or without fever 
100 
Controls Seronegative for HIV 50 
 
 
 
 
 
 
 Table 4: AGE AND SEXWISE  DISTRIBUTION CASES AND 
CONTROL 
AGE 
CASES(n=100) CONTROL(n=50) 
Male(%) Female(%) % Male(%) Female(%) % 
16-20 3(4.2) 1(3.3) 4 4(14.2) 3(13.6) 14 
21-30 16(22.8) 10(33.3) 26 4(14.2) 7(31.8) 22 
31-40 24(34.3) 11(36.7) 35 7(25) 6(27.3) 28 
41-50 18(25.7) 4(13.3) 22 3(10.7) 3(13.6) 12 
51-60 7(10) 3(10) 10 3(10.7) 1(4.5) 10 
>65 2(2.8) 1(3.3) 3 7(25) 2(9.09) 14 
 70 30  28 22  
 
Both the study groups included individuals >16 years and both sexes. 
Cases included 70 males and 30 females and control group had 28 males and 
22 females. 
Majority of the male cases in the study population belonged to the age 
group of 31-40 years (28%) and in  control group, 31-40years (25%) and >65 
years(25%) were commoner. Males outnumbered female in both cases 
and controls.  
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  Table 4: DEMOGRAPHIC DISTRIBUTION OF CASES 
 MALE FEMALE TOTAL 
RURAL 42 24 66 
URBAN 28 6 34 
TOTAL 70 30 100 
 
66% of cases were reported from rural population and 34% cases from 
urban population. 
 
Table 5: EDUCATIONAL STATUS 
OCCUPATION MALES
(n=70) 
% FEMALE
(n=30) 
% Total 
% 
Illiterates 13 18.5 11 36.6 24 
Primary school 15 21.4 7 23.3 22 
High school 18 25.7 5 16.6 23 
Higher 
secondary 
12 17.1 6 20 18 
Graduates  7 10 1 3.3 8 
Technical 5 7.1 - - 5 
Total  70  30  100 
Illiterates contributed about 24% of study population 
 
Table 6: RISK BEHAVIOUR OF CASES 
S 
NO 
RISK 
BEHAVIOR 
MALE 
(n=70) 
% 
FEMALE
(n=30) 
% 
TOTAL
(%) 
1 Smoking 52 74.2 - - 52 
2 Alcohol 47 67.1 - - 47 
3 
Multiple 
partners 
58 82.8 2 6.6 60 
4 
Homosexual 
behavior 
6 8.5 - - 6 
5 
Spouse 
positive 
56 80 28 93.3 84 
6 
VDRL 
positive 
32 45.7 6 20 38 
 
74.2% and 47% of male population were indulged in smoking and 
alcoholism respectively.  Homosexual behavior was observed in 8.5% study 
population. 
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Table 7: STAGING OF THE DISEASE (WHO staging, 2007): 
STAGE 
MALE 
(n=70) 
% 
FEMALE 
(n=30) 
% TOTAL (%) 
I 10 14.2 7 23.3 17 
II 12 17.1 1 3.3 13 
III 19 27.1 13 43.3 32 
IV 29 30 9 30 38 
 
Most of the cases were in stage IV disease (38%) 
 
Table 8: CD4 DISTRIBUTION AMONG THE CASES 
CD4 
COUNTS 
MALES 
(n=70) 
% FEMALES 
(n=30) 
% Total 
(%) 
<50 5 7.1 1 3.3 6 
51-100 8 11.4 4 13.3 12 
101-200 19 27.1 5 16.6 24 
201-500 23 32.8 16 53.3 39 
501-750 8 11.4 2 6.6 10 
>750 7 10 2 6.6 9 
39% of cases were having CD4 counts between 201- 500. 
 
 
Table 9: 
DISTRIBUTION OF CO-MORBID ILLNESS IN HIV INFECTED 
CASES 
S no 
Co-morbid 
illness 
Male 
(n=70) 
% 
Female 
(n=30) 
% 
Total 
(%) 
1 Hypertension 17 24.2 5 16.6 22 
2 
Diabetes 
Mellitus 
10 14.2 2 6.6 12 
3 Asthma 7 10 10 33.3 17 
4 Cirrhosis 5 7.1 - - 5 
5 
Renal 
disease 
10 14.2 1 3.3 11 
6 
Previously 
treated for 
TB 
27 38.5 8 26.6 35 
 
Majority of cases had been previous treated for tuberculosis (35%). 
Diabetes mellitus and renal diseases were associated with 12% and 11% of 
study subjects. 
 
 
Table 10: CLINICAL SYMPTOMATOLOGY CORRELATION  
WITH BSI 
S no Clinical features No of 
Patients(n=100)
% No of pts 
with 
BSI(%) 
1 Fever 30 30 15(65.2) 
2 Wt Loss >10% 75 75 23(100) 
3 Generalised 
Lymphadenopathy 
17 17 10(43.4) 
4 Persistent Cough 24 24 12(52.2) 
5 Persistent Diarrhoea 50 50 13(56.5) 
6 Genital Ulcers 12 12 2(8.6) 
7 Oral Thrush 29 29 9(39.1) 
8 Skin Lesions 29 29 13(56.5) 
9 Anemia 78 78 12(52.2) 
10 Jaundice 34 34 6(26.1) 
11 Neurological 
Symptoms* 
18 18 4(17.3) 
12 Tubercular infection 23 23 12(52.1) 
 
* Includes headache, neck stiffness, hemiparesis, hemiplegia.  
Fever was presenting symptom in only 30% of cases. 23% of cases were on 
treatment for tuberculosis. 
Table 11: PREVALENCE OF ETIOLOGIC AGENTS 
Study group Total Positive % 
Cases  100 23 23 
Controls 50 7 14 
Total  150 30 20 
        P= 0.0062 
23 isolates were obtained from cases and 7 isolates from control 
group. In statistical analysis, by Pearson Chi-square test, P =0.0062 .This is 
statistically significant indicating the increased prevalence of infection in 
HIV patients. 
Table12: EPIDEMIOLOGY OF BSI IN CASES AND CONTROLS 
 HIV infected 
Cases (n=23) 
HIV uninfected 
controls(n=7) 
No of BSI 
episodes 
% No of BSI 
episodes 
% 
Community 
acquired 
18 78.3 4  
Nosocomial 
acquired 
5 21.7 3  
                 P=0.538 
21.7% of cases were nosocomial acquired and 42.9% of controls were 
found in nosocomial settings. In statistical analysis, by Pearson Chi- Square 
test, P=0.538, which is statistically insignificant, showing no difference in 
epidemiology of infections between cases and controls. 
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 Table 13: ETIOLOGIC AGENTS IN THE STUDY POPULATION 
Etiologic agents 
Cases(n=23) Controls (n=7) 
No of 
Isolates % 
No of 
Isolates % 
GRAM POSITIVE COCCI 9 39.1 4 57.1 
Staphylococcus  epidermidis 4 17.4 2 28.5 
Staphylococcus aureus 3 13 1 14.3 
Staphylococcus schleiferi 
subsp schleiferi 1 4.3 - - 
Enterococcus  fecalis 1 4.3 1 14.3 
GRAM NEGATIVE  
BACTERIA 7 30.4 3 42.8 
Escherichia coli 2 8.6 1 14.3
Proteus mirabilis 1 4.3 - - 
Proteus vulgaris 1 4.3 - - 
Citrobacter koseri 1 4.3 - - 
Klebsiella oxytoca - - 1 14.3 
Salmonella paratyphi B 1 4.3 - - 
Pseudomonas aeruginosa 1 4.3 - - 
Acinetobacter spp - - 1 14.3 
FUNGI 4 17.4 - - 
Candida albicans 2 8.6 - - 
Candida tropicalis 1 4.3 - - 
Cryptococcus spp 1 4.3 - - 
PARASITES 3 13 - - 
Plasmodium falciparum 1 4.3 - - 
Plasmodium vivax 2 8.6 - - 
Total 23 100 7 100 
 
Gram positive bacteria were the commonest (39.1%).Coagulase 
negative Staphylococci was the most commonest isolate (21.7%) among 
cases. 
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Table 14: ANTIMICROBIAL SUSCEPTIBILITY OF GRAM-
POSITIVE BACTERIA CAUSING BSI IN HIV INFECTED 
INDIVIDUALS (CA-COMMUNITY ACQUIRED, NA- 
NOSOCOMIAL ACQUIRED) 
 
SNO Etiologic 
agents 
Epidemiology 
of infection  
Sensitivity for antibiotics 
P AC Co Ak Cf Cp E Ox V
1 Staphylococcus  
epidermidis 
CA R R S R R S S S S 
2 Staphylococcus  
epidermidis 
NA S S S S S S S S S 
3 Staphylococcus  
Epidermidis 
NA R R S S S S R S S 
4 Staphylococcus  
epidermidis 
CA R S R R S R S S S 
5 Staphylococcus 
aureus 
NA R S S S R S R S S 
6 Staphylococcus 
aureus 
CA R R S S S R S S S 
7 Staphylococcus 
aureus 
CA S S R R S S S S S 
8 Staphylococcus 
schleiferi  
subsp schleiferi 
CA R S R R S S S S S 
9 Enterococcus 
fecalis 
CA R S - R S - S R S 
 
Staphylococcus spp including Staphylococcus aureus were sensitive to 
many of the common antibiotics, specifically, none was resistant to 
methicillin and vancomycin. ( P-Penicillin, AC-Amoxycillin Clavulanic 
acid, Co- Cotrimoxazole, E- Erythromycin, V-Vancomycin, Cp-Cephalexin, 
Cf-Ciprofloxacin, Ak-Amikacin, Ox- oxacillin) 
Table 15: ANTIMICROBIAL SUSCEPTIBILITY OF GRAM-
NEGATIVE BACTERIA CAUSING BSI IN HIV INFECTED 
INDIVIDUALS 
SNO Etiologic 
agents 
Epidemiology 
of infection  
Sensitivity for antibiotics 
Cef Cf Of Ak Gm CFS C TE I 
1 Escherichia 
coli 
CA 
S S S R R S S S S
2 Escherichia 
coli 
CA 
S R S S R S R R S
3 Citrobacter 
koseri 
CA 
S S S S S S S - S
4 Salmonella 
paratyphi B 
CA 
S S S S - S S - S
5 Proteus 
vulgaris 
CA 
S S R S R S R R S
6 Proteus 
mirabilis 
CA 
S S S S S S S R S
7 Pseudomonas 
aeruginosa 
NA 
S S S S R S S R S
 
All of the gram negative bacterias were sensitive to third generation of 
cephalosporins, indicating absence of ESBL production. 
(Cef- Cefotaxime, Cf- Ciprofloxacin, Of- Ofloxacin, Ak- Amikacin, Gm- 
Gentamycin, CFS- Cefaperazone Sulbactum, TE-Tetracycline, C-
Chloramphenicol, I- Imipenam) 
Table 16: ANTIMICROBIAL SUSCEPTIBILITY OF GRAM-
POSITIVE BACTERIA CAUSING BSI IN HIV UNINFECTED 
CONTROLS 
SNO Etiologic 
agents 
Epidemiology 
of infection  
Sensitivity for antibiotics 
P AC Co Ak Cf Cp E Ox V
1 Staphylococcus  
epidermidis 
CA R R S R R S S S S 
2 Staphylococcus  
Epidermidis 
NA R R R R S R S R S 
3 Staphylococcus 
aureus(MRSA) 
NA R R R R S R R R S 
4 Enterococcus 
spp 
CA R R R R S R S - S 
 
Control group showed Methicillin resistance among nosocomial 
acquired strains of CoNS and Staphylococcus aureus. 
 
 
 
 
 
 
Table 17: ANTIMICROBIAL SUSCEPTIBILITY OF GRAM-
NEGATIVE BACTERIA CAUSING BSI IN HIV UNINFECTED 
CONTROLS 
SNO Etiologic 
agents 
Epidemiology 
of infection  
Sensitivity for antibiotics 
Cef Cf Of Ak Gm CFS C TE I 
1 Escherichia 
coli 
CA 
S S S S R S R R S
2 Klebsiella 
oxytoca 
CA 
R R S R R R R R S
3 Acinetobacter 
spp 
NA 
R S S S S S R R S
 
Klebsiella oxytoca was an ESBL producer, multidrug resistant, 
sensitive to ofloxacin and Imipenam. 
 
 
 
 
 
 
Table 18: PREDISPOSING FACTORS OF BSI IN HIV INFECTED 
CASES 
S 
no 
Predisposing 
factors 
Cases (n=100) Controls(n=50) 
With BSI Without BSI With BSI Without 
BSI 
No % No  % No % No  % 
1 Use of 
Intravenous 
catheter 
7 30.4 12 15.6 3 42.8 2 4.7 
2 Prev 
opportunistic 
Infections ≥2 
10 43.5 21 27.27 - - - - 
3 Anemia  12 52.2 66 85.7 2 28.6 8 18.6 
4 Neutropenia 8 34.8 3 3.9 1 14.3 - - 
5 Prev Antibiotic 
therapy 
4 17.4 23 29.9 3 42.8 5 11.6 
            P=0.0003 
 
In statistical analysis, by Pearson Chi- square test P=0.0003, 
intravenous catheters and anemia are independent factors associated with 
BSI in cases. 
 
Table 19: SOURCE OF INFECTION IN BSI POSITIVE CASES 
S no Source of infection Cases Controls 
No % No % 
1 Respiratory tract 1 4.3 1 14.3 
2 IV catheter 5 21.7 2 28.6 
3 Genitourinary tract 3 13 1 14.3 
4 Skin 2 8.7 1 14.3 
5 Bowel /Peritoneum 2 8.7 - - 
6 Biliary tract 0 0 - - 
7 Others  4 17.4 1 14.3 
8 Unknown  8 34.8 1 14.3 
 
Intravenous catheters (21.7%) were the common sources associated 
with BSI followed by genitourinary sources (13%). 
 
 
 
 
 
 
 
Table 20: DISTRIBUTION OF PATHOGENS AMONG DIFFERENT 
AGE GROUPS AND GENDER IN STUDY POPULATION 
Age 
(years) 
Cases(n=100) Controls(n=50) 
Male Female Male Female 
To
ta
l 
Po
si
tiv
e 
%
 
To
ta
l 
Po
si
tiv
e 
%
 
To
ta
l 
Po
si
tiv
e 
%
 
To
ta
l 
Po
si
tiv
e 
%
 
16-20 3 1 4.34 1 - - 4 - - 3 1 14.3 
21-30 16 2 8.7 10 1 4.34 4 - - 7 1 14.3 
31-40 24 7 30.4 11 2 8.7 7 1 14.3 6 - - 
41-50 18 7 30.4 4 1 4.34 3 - - 3 - - 
51-60 7 2 8.7 3 - - 3 3 42.8 1 1 14.3 
>65 2 - - 1 - - 7 - - 2 - - 
 70 19  30 4  28 4  22 3  
 
BSIs were common in age group of 31-40years (30.4%) and 41-50 
years (30.4%) among male cases and 31-40 years (8.7%) of female cases, 
whereas BSI were common in 51-60 years (42.8%) of male control 
population. 
 
 
 
 
Table -21:  
BSI ISOLATES IN HIV POSITIVE INDIVIDUALS AND CD4 
COUNTS 
CD4 counts 
(cells/mm3) 
<100 100-200 200-500 Total 
Male Female Male Female Male female 
Staphylococcus 
epidermidis 2 1 - - 1 - 4 
Staphylococcus 
aureus 1 - 1 1 - - 3 
Staphylococcus 
schleiferi subsp 
schleiferi 
1 - - - - - 1 
Enterococcus 
fecalis 1 - - - - - 1 
Escherichia coli - - 1 - 1 - 2 
Citrobacter koseri - - 1 - - - 1 
Salmonella 
paratyphi B 1 - - - - - 1 
Proteus vulgaris - - 1 - - - 1 
Proteus mirabilis - - - - - 1 1 
Pseudomonas 
aeruginosa - - 1 - - - 1 
Candida albicans 1 - - - 1 - 2 
Candida tropicalis 1 - - - - - 1
Cryptococcus spp 1 - - - - - 1 
Plasmodium 
falciparum 1 - - - - - 1 
Plasmodium vivax - - - 1 1 - 2
Total 10 1 5 2 4 1 23 
 
Coagulase negative Staphylococci were commonly associated with 
BSIs in patients with CD4 counts <100 cells/m3 
 
 
Table 22: CORRELATION OF BSI WITH CD4 COUNTS (N=23) 
CD4 range 
(cells/ 
uL of blood) 
 
Cases (n=100)  
Male (n=70) Female (n=30) Total 
positives 
% 
To
ta
l 
Po
sit
iv
e 
%
 
To
ta
l 
Po
sit
iv
e 
%
 
<50 5 4 17.4 1 - - 17.4 
51-100 8 6 26.1 4 1 4.3 30.5 
101-200 19 4 17.3 5 2 8.7 26.1 
201-500 23 5 21.7 16 1 4.3 26.1 
>500 15 - - 4 - - - 
 70 19  30 4   
 
  Most BSIs were common in CD4 counts less than 100(47.9%). 
Table 23:  
DISTRIBUTION OF CASES WITH REGARD TO HAART 
TREATMENT  
 
 
No of patients 
(n=100) 
% 
No of 
Patients 
with BSI 
% 
On HAART 72 72 18 78.3 
Not on HAART 28 28 5 21.7 
 100  23  
72% of the patients were under HAART and 28% of the patients were 
not on HAART. Majority of the patients were on HAART for duration 
below 3 months. 
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DISCUSSION 
Bloodstream infections (BSIs) are a major cause of illness in HIV-
infected persons. It has been noted that the pandemic affects mainly 
sexually-active age-groups, the highest prevalence was in patients with low 
CD4 counts and clinical signs of infection. Since the beginning of HIV 
disease, different studies have reported that bacterial infections were 
common in HIV infected patients because of abnormalities in humoral, 
cellular, and mucosal immunity. In addition, HIV-infected patients had an 
increased risk of bacteremia during bacterial infections 21, 73. Hence this 
study was done to determine the prevalence of nonmycobacterial bacteremia 
and fungemia and determine the antimicrobial susceptibility pattern of the 
isolates from HIV patients and to correlate it with the CD4 count of the 
patients. 
In the present study, majority of the patients were in the age group of 
31-40 years (35%) (Table-3). This correlated with the study of CA Enwuru 
et al 2008, in which majority of the patients were within 31-40 years of age 
accounting for 42%. , and also the study of Omeñaca C and Turett G et al 
with 38% majority within 31-40 years of age. In contrast, in the study done 
by Bandar et al 2006, majority of the patients were in the age group of 20-30 
years (85%).  
There was a male preponderance accounting for 70% in this study 
(Table -3) VP Baradkar et 2009, Piroon Mootsikapun 2005, Prinscilla da et 
al 2002, also reported similar results in their studies. In contrast, Latiff et al 
2004 showed female preponderance constituting 74.7% of the study group 
also Obi et al. established that there were more HIV-positive females than 
males in studies in South Africa, indicating a ‘gender bias’45. 
 Majority of the cases (66%) in our study population belonged to rural 
areas (Table-4) and most of their educational status (69%) were below higher 
secondary level (Table-5), depicting the lack of awareness regarding the 
disease prevention and early screening among the study population. 
Table 6 shows high risk behaviours among the HIV infected cases. 
Homosexual behavior was prevalent among 8.5% of the study population, 
which was similar to two studies in high HIV prevalence areas of India, 
Mumbai and Chennai, prevalence rates of 9.6% and 6.8% were reported in 
MSM respectively by Godbole S et al and Mehendale S et al, 200524. The 
pattern risk behavior showed large percentage of males (82.8%) had multiple 
sexual partners, similar to study of Kumar et al, 2008. 
Majority of study population were in stage IV of disease (Table 7), 
done based on WHO staging for the year. CD4 counts of 39% of study cases 
were between 200- 500 (Table 8).   
Comorbid conditions reported in this study were  Cirrhosis (5%), 
renal diseases (11%), asthma and COPD (17%) were independent risk 
factors with diabetes mellitus (12%) and hypertension (22%) as per Table 9. 
 Fever was presenting symptom only in 30% of cases in the present 
study. The lower percentage presenting with fever may be attributed to the 
profound immunosuppression in these patients. Other neurological 
manifestations were seen in 18% and tubercular infection was found among 
23% of study population. Weight loss (75%), and anemia (78%) were 
consistently associated with majority of cases as depicted in table 10. 
 In this study, blood stream infections were found to be 23 of 100 cases 
and 7 of 50 controls (Table11). Many studies by Fichtenbaum CJ et al 1995, 
Ssali F et al 1998, have demonstrated that the prevalence of bacteremia in 
HIV infected patients who have fever and are hospitalized, ranges from 5 to 
28% . In 2000, Ippolito et al. also recorded 12.1% cases of bloodstream 
infections in a prospective multicentre study in HIV patients with advanced 
stage of the disease. Similarly, 30% prevalence rate of bloodstream 
infections was recorded in Malawian patients. 
Epidemiology of infection among the cases and controls as in table 14 
showed 21.7% infection were nosocomial acquired and 78.3 being 
community acquired. In HIV-infected patients, community-acquired and 
nosocomial bacteremia were found in 78.5%and 21.5%, respectively and 
most were monomicrobial as revealed by Ssali et al,1998 in their study. This 
prevalence of bacteremia is consistent with earlier reports from similar 
patient populations in Rwanda and Kenya55, but lower than the 42% 
prevalence reported in Tanzania7. In African studies in which both febrile 
and afebrile patients were included, the frequency of bacteremia was lower52. 
Etiologic agents were more commonly Gram positive bacteria (39.1%) 
with Coagulase negative Staphylococcus (17.4%), being the commonest 
isolate in both community acquired and nosocomial acquired cases (Table 
15). Gram-positive bacteria are responsible for most of the bacteremias in 
hospitalized HIV-positive patients62. More Gram-positive than Gram-
negative organisms were isolated from the blood stream of the subjects in a 
study by Chierakul et al, 2004. Gram negative bacteria isolated from the 
study subjects included E.coli (8.6%), Proteus mirabilis (4.3%), Proteus 
vulgaris(4.3%),  Salmonella paratyphiB (4.3%), Citrobacter koseri (4.3%), 
Pseudomonas aeruginosa (4.3%).Fungal isolates like Candida albicans 
(4.3%), Candida tropicalis (4.3%), and Cryptococcus neoformans (4.3%). 
Plasmodium vivax (8.6%) and Plasmodium falciparum(4.3%), found among 
the isolates were identified by peripheral smear. 
Non typhoidal Salmonella were commonly associated with blood 
stream infections as established earlier by the studies of  Bonadio et al9. 
Many studies have shown Staphylococcus species to be the most common 
isolates in blood9, 20, 44. Gooze and Choi et al. had established that coagulase-
negative staphylococci are a major cause of infection in immuno-
compromised patients15,26. Similarly, Bonadio et al. reported that the most 
frequently-isolated bacteria were coagulase-negative staphylococci14. 
 Results of antimicrobial susceptibility tests in the present study, by 
Kirby Bauer Disk Diffusion method, revealed that most coagulase-negative 
staphylococci were susceptible to most antimicrobials screened. Specifically, 
none was resistant to methicillin and vancomycin (Table 15) compared with 
controls which were multidrug resistant (Table17). This is in line with results 
of previous studies, Shittu et al. 2006, reported that all isolates of S. aureus 
from clinical samples were susceptible to teicoplanin, vancomycin, fusidic 
acid, and rifampicin but showed high resistance to penicillin, sulphonamides, 
and tetracycline56.  
The Gram-negative bacterial isolates from this study also showed 
good sensitivity patterns to third generation of cephalosporins (Table 16) 
similar to the study with ceftazidin, cefotaxime, augmentin, and cefuroxime,  
by Adeyemi AI et al. 2010, indicating that they do not produce extended 
betalactamase . However, they too showed varying resistance to older-
generation antibiotics, such as ampicillin, tetracycline, chloramphenicol. The 
multi-drug resistance patterns observed in this study are similar to those 
earlier reported by Adeleye and Adesoye1. 
The common sources of blood stream infection in patients with HIV 
infection include the lungs, skin, subcutaneous tissue, and intravascular 
catheters41,49. In the present study (Table 19), the most common source of 
BSI was intravascular catheters (21.7%), followed by genitourinary sources 
(13%), depicting intravascular catheter as a important predisposing factor 
causing bacteremia (Table 18), in correlation with study by Philips et al, 
1995. No intravenous or other forms of drug abusers were observed in this 
study. 
 The present study also revealed, strong correlation of BSI with 
immunosuppression. Majority of patients (74%) with blood stream infection 
had CD4 counts less than 100 (Table 21 &22) similar to that observed in the 
study by Adeleye et al, where 67% of the patients had CD4 counts of <200 
cells/μL of blood. In fact, 10% of outpatients with HIV and CD4 count <100 
cells/mm3 had a BSI by Piroon Mootsikapun et al,2005, a prevalence similar 
to that seen in a previous study of febrile, HIV-infected inpatients in 
Thailand. 
72% of study population was on HAART (Table 23). Most of the 
studies reported decreased incidence of BSIs in patients on ART. In this 
study, high prevalence of disease in patients with HAART (78.3%) may be 
because duration of HAART in these individuals were less than 3 months. 
  
SUMMARY & CONCLUSION 
Blood samples of randomly selected 100 HIV seropositive subjects 
inpatients (cases) and 50 seronegative inpatients (control), in Chennai, was 
examined for bloodstream infections. Blood culture in BHI biphasic medium 
and trypticase soy broth were done. Subcultures done in Blood agar, 
chocolate agar, differential agar and Sabouraud’s dextrose agar in 48 hours. 
CD4 cell counts were done for HIV infected individuals and were used as 
indicators of immune status to analyze the results obtained.  
♦ Blood stream infections were identified in 23% of cases and 7% of controls. 
♦ Gram positive bacteria were more prevalent than gram negative bacteria.  
♦ CoNS was the commonest pathogen identified in the cases (17.4%), 
followed by Staphylococcus aureus (13%), Escherichia coli, Candida 
albicans, Plasmodium vivax were 8.6% each. 
♦ Other pathogens isolated include Staphylococcus schleiferi subsp schleiferi, 
Enterococcus fecalis, Citrobacter koseri, Salmonella paratyphi B, 
Pseudomonas aeruginosa, Candida tropicalis, Cryptococcus neoformans, 
and Plasmodium falciparum. 
♦ Among controls, CoNS was the commonest isolate but showed multidrug 
resistance. 
♦ CoNS, isolated from repeated subcultures alone were considered significant, 
others were taken as insignificant and reported as no growth.  
♦ Methicillin resistance and ESBL producers were not found among the 
isolates. The spectrum of pathogens causing BSI in these HIV patients were 
mainly the normal microflora of the local environment showing sensitivity to 
most antimicrobials. 
♦ Intravenous catheters constituted as a significant predisposing factor. 
♦ BSI were common in age group of 31-50years (60.8%) of male cases and  
31-40 years (8.7%) of female cases, whereas BSI were common in 51-60 
years (42.8%) of male control population.  
♦ Majority of cases with blood stream infections were found to have CD4 cell 
counts <100cells/mm3. 
♦ Duration of HAART also influences the incidence and mortality , due to 
BSI. 
 
BSI in adult HIV-infected patients is often caused by Gram-positive 
pathogens in both Community Acquired and Nosocomial settings. Coagulase 
negative Staphylococci are increasingly associated with blood stream 
infections in these patients, especially in profound immunosuppression with 
CD4 counts <100 cells/mm3.  
  Early  detection of HIV infected individuals, timely review of these 
patients with their CD4 counts, thereby leading to initiation of HAART at 
the earliest will prevent  bacteremia, fungemia, and other opportunistic 
infections, decreasing the mortality due to these illnesses. 
PROFORMA 
1. Name    :   
2. Patient Identity No/ART No.     : 
3. Age/ Sex      : 
4. Marital status      : 
5. Address       : 
6. Education       : 
7. Occupation      : 
8. Religion       : 
9. Referring Centre (if any)       : 
II. RISK FACTOR QUESTIONNAIRE 
1. Reasons for HIV testing 
(Voluntary/Antenatal Check Up/Referral from STI clinic/ 
Positive Consort/Symptomatic conditions attributing to 
 HIV infection/AIDS defining Illness/Others ) : 
2. H/o Smoking/ Alcohol intake/ Drug abuse  : 
3. H/o Blood Transfusion/ any previous surgery/  
Dental procedures    : 
4. H/o tattooing   : 
5. H/o needle stick injuries in  
health care professionals  : 
6. H/o Spouse HIV+ve/ Parent to Child transmission: 
7. H/o Premarital Sex/ Exposure to multiple sexual partners/ 
Exposed to CSWs  : 
8. H/o use of contraception  : 
a. Type 
9. H/o homosexual partner  : 
10. H/o comorbid conditions : 
(Diabetes/Hypertension/Coronary artery disease) 
II. ILLNESS DEFINING HISTORY 
1. H/o fever 
a. Duration 
b. Treatment (if any) 
2. H/o weight loss 
3. H/o persistent diarrhea 
a. Duration 
b. Treatment (if any) 
4. H/o generalized/localized lymphadenopathy 
5. H/o persistent cough 
a. Duration 
b. Treatment (if any) 
6. H/o tubercular infection 
a. Treatment (if any) 
7. H/o genital ulcers/vesicles 
8. H/o VDRL tested reactive 
 
 
9. H/o Vaginal Discharge 
a. If any, Nature of discharge 
b. Blood stained/not 
10. H/o PAP smear/biopsy/Post coital bleed 
11. H/o visual Changes/blindness 
12. H/o  headache 
a. Nature 
b. Duration 
c. Associated with nausea/vomiting 
13. H/o neurological symptoms/ 
 Neurologic signs on referral card 
a. Memory deficits 
b. Numbness 
c. Weakness in limbs 
d. Seizures 
14. H/o Skin lesions 
15. H/o mood disorders 
16. H/o date of initiation of ART 
17. H/o treatment for OIs 
18. H/o of drug adverse effects 
Laboratory Evaluation: 
• Hematological Investigation: 
1. Hemoglobin 
2. Complete blood count 
• Others:  CXR 
 
 
• Microbiological Investigation 
HIV testing   
CD4 counts 
Peripheral smear by Leishman’s staining 
Blood cultures in  
Brain Heart Infusion Biphasic medium 
Trypticase soy broth 
Subcultures in 
 Blood Agar 
 Chocolate Agar 
 Nutrient Agar 
 MacConkey Agar 
Biochemical reactions 
Antimicrobial susceptibility testing by Disc Diffusion method 
 
 
 
 
 
 
 
 
 
 
ABBREIVATIONS 
HIV- Human Immunodeficiency Virus 
AIDS- Acquired Immuno Deficiency Syndrome 
CD-Cluster Differentiation 
BSI- Blood Stream Infections 
CMV- Cytomegalovirus 
ART- Anti Retroviral Therapy 
HAART- Highly Active Anti Retroviral Therapy 
NACO- National AIDS Control Organisation 
 
 
 
 
 
 
 
 
 APPENDIX 
I. STAINING 
Gram staining 
Methyl violet (2%) – l0g Methyl violet in l00ml absolute alcohol in 1litre of  
distilled water (primary stain) 
Grams Iodine – l0g Iodine in 20g KI (fixative) 
Acetone – Decolourising agent 
Carbol fuchsin 1% – Secondary stain 
India Ink Staining 
 India Ink     150 ml 
 Merthiolate     3 ml 
 (1:1000) 
 Tween 80   0.1ml 
 (1:10,000) 
Mixed, filtered and kept in bottles. 
Leishman staining 
0.15% Leishman powder dissolved in 100% methanol. Used after 24hrs. 
Phosphate buffer (Sorensen)  
Stock A:  0.2M sodium di-hydrogen orthophosphate (mw 156).  
 3.12g dissolved in 100ml distilled water. 
Stock B:  0.2M di-sodium hydrogen orthophosphate (mw 142).  
2.83g dissolved in 100ml ditilled water. 
25.5ml of A added to 24.5ml of B, pH adjusted to 6.8 
II. CULTURE MEDIA 
Brain Heart Infusion Biphasic Medium 
Sodium citrate lgm 
Sodium chloride 4gm 
Sodium phosphate 5gm 
Dextrose l0 gm 
Peptone 1 0gm 
Brain Heart Infusion Broth 
Brain infusion broth 250ml 
Heart infusion broth 750ml 
Sodium polyanethol sulphonate 0.25gm 
 
Obtain Ox brain and heart. Remove all fat from the heart. Cut into 
small pieces and grind. Add distilled water three times and keep at 4°C 
overnight. From the brain, remove meninges fully and then, weigh. Add 
distilled water and mash by using hand. Keep in the cooler over night. Next 
morning boil the brain and heart separately for 30 minutes. Then filtered 
through cotton layer. Measure each broth separately. Mix both infusions and 
the remaining ingredients. Dissolve well and adjust pH of the entire amount 
to 7.4 to 7.6. Autoclave at 121° C for 15 minutes.  
Brain Heart Infusion Agar Slant 
 Same as above, in addition it contains agar. Autoclave at 121°C for 15 
minutes. Distribute in screw capped bottles and slant is allowed to solidify, 
then broth is distributed in bottles. 
Trypticase Soy broth 
 Pancreatic digest or casein  17.0 gram 
 Enzymatic Soy Digest   3.0 gram 
Sodium chloride    5.0 gram 
Dipotassium phosphate    2.5 gram 
Dextrose      2.5 gram 
Sodium Polyanetholsulfonate   0.3gram 
Final pH adjusted to 7.3± 0.2. Autoclave at 121°C for 15 minutes and 
distribute in screw capped bottles . 
Mac Conkey agar 
                   Peptone                                    -             20g 
                   Sodium taurocholate                -               5g 
                   Distilled Water                          -              1 ltr 
                   Agar                                          -             20g 
                   2% neutral red in 50% ethanol -             3.5ml 
                   10% lactose solution                 -             l00mI 
                 Dissolve peptone and taurocholate in water by heating. Add agar 
and dissolve it in steamer. Adjust pH to 7.5. Add lactose and neutral red 
shake well and mix. Heat in free steam (100°C) for 1 hour, then autoclave at 
115°C for 15 minutes. 
Blood agar (5% sheep blood agar) 
                     Peptone                    -          l0g 
                     Nacl                          -          5g 
                     Distilled water           -         1 Ltr 
                     Agar                          -         10g 
               Dissolve ingredients in distilled water by boiling, and add 5% 
sheep blood (sterile) at 55°C adjust pH to 7.4. 
Chocolate Agar 
                      Sterile defibrinated blood      -         10 ml 
                      Nutrient Agar (melted)           -         100 ml 
           When the temperature was about 75°C, sterile blood was added with 
constant agitation. After addition of blood, kept in water bath and heating 
was continued till the blood changed to chocolate colour. Cooled to about 
50° C and poured about 15ml into petri dishes with sterile precaution. 
 
 
 
Sabouraud’s Dextrose Agar With Antibiotics 
          Composition of Sabouraud’s Dextrose Agar (Emmons Modification) 
                      Dextrose           -              20 gm 
                      Peptone            -              10 g 
                      Agar                  -              20 g 
                      Distilled water   -               1000 ml 
                      Final pH            -               6.9 
         The ingredients are dissolved by boiling. Gentamycin was 
dissolved in 10 ml of 95% alcohol and added to boiling medium. 
Autoclave at 121°C for 15 minutes, dispense in tubes and allow to cool in 
slanted position. 
Mueller- Hinton Agar 
                      Beef infusion                   -         300ml 
                      Caesein hydrolysate       -          17.5g 
                      Starch                             -           1.5g 
                      Agar                               -           10g 
                       Distilled water                 -           1ltr 
                       pH                                  =           7.4 
         Sterilise by autoclaving at 1210C for 20 mins 
Cornmeal Agar 
                      Cornmeal         -         40g 
                      Agar                 -         15g 
                      Water               -          1 litre 
             Boil the cornmeal in 1 litre of water for 60 min.Filter through muslin 
and add the agar. Steam to dissolve, dispense in required amounts and 
autoclave at 115° C for 30min. allow to cool to 50°C and pour approximately 
20 ml amounts into Petri dishes. 
II. MEDIA REQUIRED FOR BIOCHEMICAL IDENTIFICATION 
OF BACTERIA 
Oxidase Reagent 
                 Tetra methyl p-phenelene diamine dihyrochloride- 
                  1% aqueous solution. 
Catalase 
                  3% hydrogen peroxide 
Indole test 
                  Kovac’s reagent 
                  Amyl or isoamyl alcohol                     - 150ml 
                  Para dimethyl amino benzaldehyde  - 10g 
                  Concentrated hydrochloric acid        -  50ml 
       Dissolve the aldehyde in the alcohol and slowly add the acid. Prepare in 
small quantities and store in the refrigerator. Shake gently before use. 
Christensen’s Urease test medium 
                  Peptone                                           -          1g 
                  Sodium chloride                               -          5g 
                  Dipotassium hydrogen phosphate  -           2g 
                  Phenol red                                       -           6ml 
                  Agar                                                 -            20g 
                  Distilled water                                  -             1 ltr 
                  10% sterile solution of glucose        -              l0ml 
                  Sterile 20% urea solution                 -              l00ml 
        Sterilize the glucose and urea solutions by filtration. Prepare the basal 
medium without glucose and urea, adjust to pH 6.8-6.9 and sterilize by 
autoclaving in a flask at 121°C for 30min. Cool to about 50°C, add the 
glucose & urea, and tube the medium as slopes. 
Simmon’s Citrate Medium 
                  Koser’s medium                   -       1 ltr 
                  Agar                                     -       20g 
                  Bromothymol blue 0.2%     -       40ml 
           Dispense, autoclave’ at 121°C for 15 min and allow to set as slopes 
 
Triple Sugar Iron medium 
                   Beef Extract               -          3g 
                   Yeast extract              -          3g 
                    Peptone                      -          20g 
                    Glucose                      -           1g 
                    Lactose                      -          10g 
                    Sucrose                     -           10g 
                    Ferric citrate               -           0.3g 
                    Sodium chloride          -           5g 
                    Sodium thiosulphate   -           0.3g 
                    Agar                            -           12g 
                     Phenol red 0.2% solution -      12ml 
                     Distilled water                   -      1 ltr 
               Heat to dissolve the solids, add the indicator solution, mix and tube. 
Sterilize at 121°C for 15 min and cool to form slopes with deep butts. 
Glucose phosphate broth 
                      Peptone                                               -        5g 
                      Dipotassium hydrogen phosphate       -        5g 
                      Water                                                  -        1 ltr 
                      Glucose 10% solution                        -        50ml 
           Dissolve the peptone and phosphate and adjust the pH to 7.6. Filter 
dispense in 5ml amounts and sterilize at 121°c for 15min. Sterilize the 
glucose solution by filtration and add 0.25ml to each tube. 
 
Methyl Red Reagent 
                       Methyl Red - 10mg 
                       Ethyl alcohol - 30ml 
                       Distilled water - 20ml 
Voges Proskauer Reagent 
                        Reagent A: Alpha naphthol - 5g 
                                            Ethyl alcohol - 100ml 
                         Reagent B: Potassium hydroxide - 40g 
                                            Distilled water - 100ml 
Peptone water fermentation test medium. 
                To the basal medium of peptone water, add sterilised sugars of 1% 
indicator bromothymol blue with Durham’s tube. 
Basal medium - peptone water 
Sugar solutions: 
Sugar - 1ml 
Distilled water - l00ml 
pH = 7.6. 
Mannitol motility medium 
                     Agar                         -             5g 
                     Peptone                  -             1g 
                     Potassium nitrate    -             1g 
                     Mannitol                 -             2g 
                     Phenol red indicator 
                     Distilled water - l000ml 
                     pH = 7.2 
Potassium Nitrate Broth 
                     Potassium nitrate (KN03)           -          0.2gm 
                     Peptone                                        -          5.0gm 
                     Distilled water                             -          100ml          
The above ingredients were mixed and transferred into tubes in 5 ml amount 
and autoclaved. 
Phenyl Alanine Deaminase Test 
                      Yeast Extract 3g  
                      Dl-Phenylalamine 2 g      
                      Disodium hydrogen phosphate lg   
                      Sodium Chloride - 5 g 
                      Agar 12g  
                       Distilled water - 1 lr 
pH adjusted to 7.4, distributed in tubes and sterilized by autoclaving at 121° 
C for 1 5 minutes, allowed to solidify as long slopes. 
 
 
ganisation  
OI- Opportunistic Infections 
ESBL- Extended Spectrum Beta Lactamase 
MRSA- Methicillin Resistant Staphylococcus aureus 
SPS- Sodium polyanethol sulfonate  
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